Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

PURPOSE: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 199 chemotherapy-na...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seung Il, Kim, Myung Soo, Jeong, Chang Wook, Kwak, Cheol, Hong, Sung Kyu, Kang, Seok Ho, Joung, Jae Young, Lee, Seung Hwan, Yun, Seok Joong, Kim, Tae-Hwan, Park, Sung Woo, Jeon, Seong Soo, Kang, Minyong, Lee, Ji Youl, Chung, Byung Ha, Hong, Jun Hyuk, Ahn, Hanjong, Kim, Choung-Soo, Kwon, Dong Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946821/
https://www.ncbi.nlm.nih.gov/pubmed/31942459
http://dx.doi.org/10.4111/icu.2020.61.1.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946821/
https://www.ncbi.nlm.nih.gov/pubmed/31942459
http://dx.doi.org/10.4111/icu.2020.61.1.19

Ejemplares similares